Real guides about PrEP.
Written for our community.

Mistr vs GoFreddie (2026): Which free PrEP provider is actually better?

Both offer PrEP at $0 to uninsured Americans — but they work completely differently, and one has had a rough few years. Here's the honest breakdown.

The basics: What do both actually offer?

Mistr and GoFreddie both exist to solve the same problem: PrEP medication can cost hundreds of dollars per month without insurance — completely out of reach for many people who need it most. Both platforms partner with pharmaceutical assistance programs to make it free or near-free.

The key difference is how they deliver that experience. Mistr routes your prescription through a network of brick-and-mortar pharmacies. GoFreddie handles nearly the entire process by mail — including the lab testing kit.

GoFreddie: The faster, more convenient option

GoFreddie launched in 2021 with a simple promise: handle everything by mail and respond to every customer. On Trustpilot, they sit at a 4.8-star average across 394+ reviews — one of the highest ratings of any telehealth platform, PrEP-specific or otherwise.

The typical flow: complete a 10-minute online intake → clinician reviews and prescribes within 24–48 hours → GoFreddie mails you an at-home lab kit (HIV test, kidney function, STI screening) → you mail samples back → PrEP ships to your door, often within a week of starting.

Mistr: The OG with a mixed recent track record

Mistr has been around since 2018 and helped tens of thousands of people access PrEP at no cost. At its peak it was the top recommendation in queer communities for uninsured people. The model: telehealth prescription + local pharmacy fulfillment through the assistance network.

The advantage: a real pharmacy relationship. For people who want pharmacist access, in-person pickup, or questions about drug interactions (say, PrEP alongside HRT), this matters. The downside: their reviews have declined since 2023. Trustpilot average sits around 3.9 stars across 320+ reviews, with patterns of slow service, prescription delays, and difficulty reaching support.

The direct comparison

Bottom line

For most uninsured people starting from scratch in 2026, GoFreddie is the better experience. The at-home lab kit alone removes one of the biggest friction points. The review quality backs up the experience. And the prescription speed is genuinely fast.

Mistr is still legitimate — especially if you prefer pharmacy pickup or live in an area where mail shipping is slow. But in a direct comparison, GoFreddie wins in 2026.

Twice-yearly injectable PrEP is here — what does lenacapavir actually mean for you?

The FDA approved lenacapavir (brand name Sunlenca) as the first twice-yearly PrEP injection. Two shots a year instead of 365 pills. Here's what the real-world rollout looks like and whether you can get it online yet.

What is lenacapavir, exactly?

Lenacapavir (brand name Sunlenca, made by Gilead Sciences) is a capsid inhibitor — it blocks HIV at a stage of its lifecycle that other drugs don't target. It's so effective that it works even when other antiretrovirals have stopped working for a person on treatment.

In 2025, the FDA approved it specifically as PrEP — the first twice-yearly PrEP option. Previous injectable PrEP (cabotegravir/Apretude) required shots every two months. Twice per year is a fundamentally different category of convenience.

The clinical trial numbers

In the PURPOSE 1 trial (cisgender women in sub-Saharan Africa): 100% efficacy — zero HIV infections among participants who received lenacapavir. In PURPOSE 2 (gay and bi men, trans women and men, non-binary people): 96% effectiveness compared to estimated background infection rates in that population.

For context, daily oral PrEP achieves up to 99% protection when taken consistently. The "when taken consistently" qualifier is exactly where daily pills fall short for many people — lenacapavir removes adherence as a variable entirely.

Can I get it online yet?

Not easily, as of early 2025. Injectable medications require in-person administration — you can't self-inject these the way insulin works. This means telehealth-only platforms can't currently offer it unless they have clinical partners who can give the shot.

A few hybrid models are emerging. Watch for announcements from GoFreddie, Nurx, and larger health systems over 2025. For now, your best bets are:

• Local HIV clinic or health department (most likely to have it stocked)
• Federally qualified health centers (FQHCs), which often get early access
• Gilead's Advancing Access patient assistance covers it for uninsured people

What about cost?

Lenacapavir is covered under the ACA preventive services mandate — meaning most private insurance covers it at no cost. Medicaid coverage varies by state. Gilead's patient assistance covers uninsured patients who qualify. The drug's list price is high, but for most people in the U.S., the practical barrier will be finding an administration site, not cost.

How to get PrEP completely free — 4 real pathways that actually work

Ready, Set, PrEP. Gilead Advancing Access. State Medicaid. 340B clinics. Four routes to $0 PrEP — each works differently. We walk through each one honestly, including which online providers make enrollment easiest.

Pathway 1: ACA mandate (if you have private insurance)

Since 2019, the ACA requires most private health insurance plans to cover PrEP at zero out-of-pocket cost — no copay, no deductible applies. This covers the medication, required labs, and clinical visits. If your insurer is charging you for PrEP on an ACA-compliant plan, they may be violating federal law. Call them and ask specifically about "preventive PrEP coverage."

Pathway 2: Ready, Set, PrEP (federal program)

This federal program (run by HHS) provides free PrEP medication to uninsured Americans who test HIV-negative and have a prescription. Visit readysetprep.hiv.gov to enroll — you'll need proof of insurance status and an HIV-negative test. GoFreddie and Q Care Plus both help with enrollment on your behalf, which is significantly easier than navigating it alone.

Pathway 3: Gilead Advancing Access

Gilead's patient assistance program covers Truvada, Descovy, and lenacapavir for uninsured and underinsured people. Income thresholds are generous, and most telehealth platforms handle the application for you. GoFreddie is particularly good at this — you don't fill out paperwork yourself, they handle it.

Pathway 4: Medicaid and state programs

If you qualify for Medicaid, PrEP is covered in all 50 states. Cost-sharing varies — expansion states often have zero cost-sharing. Several states also run their own HIV prevention programs for uninsured residents. Q Care Plus and Nurx specialize in Medicaid PrEP navigation and are the best telehealth options if that's your route.

What is PrEP, and do I actually need it? A real answer, not a pamphlet.

PrEP is a daily pill (or twice-yearly injection) that prevents HIV before exposure. Up to 99% effective, widely available online, often free. Here's the honest version — who it's for, how it works, and how to start without the clinic anxiety.

The short version, right up front

PrEP (pre-exposure prophylaxis) is medication that HIV-negative people take to prevent getting HIV. When taken as prescribed, it reduces HIV risk from sex by up to 99% and from injection drug use by around 74%. It's been FDA-approved since 2012, over 500,000 Americans currently take it, and for most insured people it's completely free.

Who is it actually for?

The CDC's official guidance: any HIV-negative adult who is sexually active and could benefit. In practice, PrEP is most used by — and most urgently needed by — gay and bisexual men. About 70% of new HIV diagnoses in the U.S. are among gay and bi men, and PrEP is the most powerful prevention tool available.

It's also critically important for trans women (especially Black and Latina trans women, who face the highest HIV rates of any group), people with HIV-positive partners, people with multiple partners, and anyone who doesn't always use condoms consistently. That said — the CDC has made clear since 2021 that any provider can prescribe PrEP to any sexually active person who asks, without requiring documented risk factors.

How it works in your body

The most common oral PrEP is emtricitabine/tenofovir (Truvada, Descovy, or generics). These antiretrovirals block an enzyme HIV needs to copy itself in your cells. When the drug is present at therapeutic levels, HIV can enter your body but can't replicate — so it dies before establishing an infection.

This requires consistent daily levels, which is why adherence matters. It typically takes about 7 days to reach maximum protection for anal sex, and around 21 days for vaginal sex.

What being "on PrEP" actually looks like

Day-to-day, it's low-maintenance once you're set up:

• One pill per day — any time, with or without food
• A 90-day follow-up — HIV test, kidney check, STI screening (at-home kits from most telehealth platforms)
• Prescription renewal every 90 days — most platforms automate this
• Some people have mild nausea or headache in the first few weeks — this almost always resolves

Many people find that getting on PrEP actually makes them more proactive about their sexual health overall — the routine quarterly testing is a feature, not just a requirement.

Truvada vs Descovy: Which PrEP pill is actually right for you?

Both FDA-approved, both highly effective, both look like just "a PrEP pill" — but they're not the same drug. Generic Truvada costs less. Descovy may be gentler on bones and kidneys. And Descovy isn't approved for everyone. Here's the real breakdown.

What's actually in each pill?

Truvada contains emtricitabine (FTC) + tenofovir disoproxil fumarate (TDF). Approved as PrEP since 2012, with the longest real-world track record and affordable generics now available.

Descovy contains emtricitabine (same) + tenofovir alafenamide (TAF) — a newer version of the second ingredient. Approved as PrEP in 2019. TAF is absorbed differently: lower circulating blood levels, potentially less impact on kidneys and bone density over time.

Are they equally effective?

For anal sex and injection drug use: yes, both are considered equivalent. Descovy was shown to be non-inferior to Truvada in clinical trials for these transmission routes. The important caveat: Descovy is not FDA-approved for people at risk from vaginal sex — the relevant clinical trial didn't include enough participants in that risk category. For cisgender women and trans men with vaginas at risk from vaginal exposure, Truvada (or generic) is the recommended option.

The TAF formulation in Descovy was specifically designed to reduce kidney and bone density effects observed in some long-term TDF (Truvada) users. Clinical data shows measurably lower kidney stress markers and better bone density on Descovy over 2+ years. That said, most people on Truvada don't experience significant issues — these are statistical population-level differences, not guaranteed individual experiences. Your provider will typically suggest Descovy if you have pre-existing kidney concerns or bone density risk factors.

Generic Truvada has been available since 2020 and is substantially cheaper than brand-name Descovy. For uninsured people on assistance programs, this often doesn't matter since both are covered. But if any out-of-pocket costs apply, generic TDF/emtricitabine can be meaningfully cheaper. Descovy has no generic equivalent yet in the U.S. — a genuine equity issue in PrEP access.

What does "community-affirming" PrEP care actually mean in practice?

Every platform puts a rainbow on their site in June. Genuine affirming care is something more specific — it shows up in the intake form, in how clinicians talk about risk, in whether you ever have to explain what MSM means. Here's what to actually look for.

Why "LGBTQ+ friendly" as a badge isn't enough

Real affirming care in PrEP shows up in specific, checkable ways: the intake form language, whether HIV risk is framed as a health consideration or a moral category, whether you have to justify wanting PrEP, and whether trans patients are treated with competence on issues like PrEP interactions with HRT.

The difference matters. Research consistently shows that patients who feel judged or othered during medical care are less likely to adhere to treatment — including PrEP. Affirming care isn't a nice-to-have. It's a clinical outcome.

What to look for in an intake form

The fastest signal of a genuinely affirming provider: look at their intake form before you sign up. A good one:

• Asks about sexual practices rather than assuming heterosexuality as the default
• Includes gender identity and preferred pronouns as standard questions
• Uses terms like MSM, serodiscordant, and U=U without quotation marks or hedging
• Doesn't ask you to prove why you want PrEP or document your "risk level"

A red flag: an intake form where "unprotected heterosexual sex" is the primary risk category listed, or where MSM is treated as an unusual disclosure requiring extra explanation.

The honest summary

Platforms built specifically for queer communities — GoFreddie, Folx, Mistr, Q Care Plus — consistently outperform general telehealth platforms on affirming care. If you've had an experience that felt clinical, judgmental, or like you had to explain your own life to receive basic healthcare — that's not how this has to feel. The right provider treats PrEP as what it is: a routine health decision you're making for yourself.